Somewhat Positive Press Coverage Somewhat Unlikely to Impact Inovalon Holdings (NASDAQ:INOV) Share Price

News headlines about Inovalon Holdings (NASDAQ:INOV) have trended somewhat positive this week, according to Accern. The research firm identifies negative and positive media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Inovalon Holdings earned a news impact score of 0.12 on Accern’s scale. Accern also assigned media headlines about the technology company an impact score of 45.4462347522925 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Inovalon Holdings (NASDAQ INOV) opened at 12.95 on Friday. Inovalon Holdings has a 1-year low of $8.60 and a 1-year high of $16.64. The firm has a market capitalization of $1.89 billion, a price-to-earnings ratio of 108.82 and a beta of 1.19. The company has a 50-day moving average price of $13.08 and a 200 day moving average price of $12.65.

Inovalon Holdings (NASDAQ:INOV) last announced its earnings results on Wednesday, August 2nd. The technology company reported $0.08 earnings per share for the quarter, topping analysts’ consensus estimates of $0.07 by $0.01. Inovalon Holdings had a net margin of 4.13% and a return on equity of 5.17%. The business had revenue of $110.60 million during the quarter, compared to the consensus estimate of $108.73 million. During the same quarter last year, the firm earned $0.14 earnings per share. Inovalon Holdings’s quarterly revenue was down 10.7% on a year-over-year basis. Equities analysts anticipate that Inovalon Holdings will post $0.31 earnings per share for the current year.

A number of research analysts have recently issued reports on INOV shares. BidaskClub lowered Inovalon Holdings from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 12th. Zacks Investment Research raised Inovalon Holdings from a “hold” rating to a “buy” rating and set a $15.00 price objective on the stock in a report on Tuesday, May 9th. Finally, Robert W. Baird reiterated a “neutral” rating and set a $12.00 target price (up from $11.00) on shares of Inovalon Holdings in a research report on Friday, June 16th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company. Inovalon Holdings has a consensus rating of “Hold” and an average price target of $14.20.

TRADEMARK VIOLATION NOTICE: “Somewhat Positive Press Coverage Somewhat Unlikely to Impact Inovalon Holdings (NASDAQ:INOV) Share Price” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international copyright and trademark laws. The correct version of this report can be viewed at https://www.com-unik.info/2017/08/19/inovalon-holdings-nasdaqinov-receives-media-sentiment-score-of-0-12-updated-updated.html.

In related news, insider Shauna L. Vernal sold 19,332 shares of Inovalon Holdings stock in a transaction on Wednesday, May 24th. The shares were sold at an average price of $13.60, for a total transaction of $262,915.20. Following the completion of the transaction, the insider now owns 66,261 shares of the company’s stock, valued at $901,149.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 48.28% of the stock is owned by company insiders.

About Inovalon Holdings

Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.

Insider Buying and Selling by Quarter for Inovalon Holdings (NASDAQ:INOV)

What are top analysts saying about Inovalon Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Inovalon Holdings Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit